T0	Participants 345 381	Travis Pharmacy in Shenandoah, Iowa.
T1	Participants 391 460	Ninety-five patients from southwestern iowa and southeastern Nebraska
T2	Participants 484 571	88 were considered eligible for comparison (by continuing through week 2 of the study).
T3	Participants 940 968	MR (n = 45) and RCD (n = 43)